National Bank of Canada
AVXL icon

National Bank of Canada’s Anavex Life Sciences AVXL Stock Holding History

National Bank of Canada’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,250
Closed -$1.15M – 2862
2025
Q2 		$1.15M Buy
+1,250
New +$10.7K ﹤0.01% 1248

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

National Bank of Canada's AVXL Position: Q2 2026 in Review

National Bank of Canada reduced its Anavex Life Sciences (AVXL) stake by 33% in Q2 2026, selling an estimated $1.48K and leaving 1,000 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

National Bank of Canada first reported a position in AVXL in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.5M in Q3 2025. 78 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • National Bank of Canada held 1,000 shares of Anavex Life Sciences worth $2.58K as of Q2 2026.
  • National Bank of Canada sold 500 Anavex Life Sciences shares in Q2 2026, an estimated $1.48K.
  • Anavex Life Sciences made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2676 holding.
  • National Bank of Canada first reported a position in Anavex Life Sciences in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Anavex Life Sciences position peaked at $3.5M in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.